1. Home
  2. VERV vs NRIM Comparison

VERV vs NRIM Comparison

Compare VERV & NRIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERV
  • NRIM
  • Stock Information
  • Founded
  • VERV 2018
  • NRIM 1990
  • Country
  • VERV United States
  • NRIM United States
  • Employees
  • VERV N/A
  • NRIM N/A
  • Industry
  • VERV Medicinal Chemicals and Botanical Products
  • NRIM Savings Institutions
  • Sector
  • VERV Health Care
  • NRIM Finance
  • Exchange
  • VERV Nasdaq
  • NRIM Nasdaq
  • Market Cap
  • VERV 475.0M
  • NRIM 474.2M
  • IPO Year
  • VERV 2021
  • NRIM N/A
  • Fundamental
  • Price
  • VERV $5.50
  • NRIM $84.00
  • Analyst Decision
  • VERV Strong Buy
  • NRIM
  • Analyst Count
  • VERV 4
  • NRIM 0
  • Target Price
  • VERV $25.75
  • NRIM N/A
  • AVG Volume (30 Days)
  • VERV 1.6M
  • NRIM 24.3K
  • Earning Date
  • VERV 11-05-2024
  • NRIM 01-23-2025
  • Dividend Yield
  • VERV N/A
  • NRIM 2.88%
  • EPS Growth
  • VERV N/A
  • NRIM 22.45
  • EPS
  • VERV N/A
  • NRIM 5.86
  • Revenue
  • VERV $24,396,000.00
  • NRIM $141,590,000.00
  • Revenue This Year
  • VERV $97.47
  • NRIM N/A
  • Revenue Next Year
  • VERV N/A
  • NRIM $3.03
  • P/E Ratio
  • VERV N/A
  • NRIM $14.67
  • Revenue Growth
  • VERV 219.91
  • NRIM 12.70
  • 52 Week Low
  • VERV $4.31
  • NRIM $43.92
  • 52 Week High
  • VERV $19.34
  • NRIM $91.72
  • Technical
  • Relative Strength Index (RSI)
  • VERV 44.33
  • NRIM 51.76
  • Support Level
  • VERV $5.19
  • NRIM $83.29
  • Resistance Level
  • VERV $7.40
  • NRIM $89.11
  • Average True Range (ATR)
  • VERV 0.65
  • NRIM 2.54
  • MACD
  • VERV -0.12
  • NRIM -0.89
  • Stochastic Oscillator
  • VERV 7.88
  • NRIM 5.84

About VERV Verve Therapeutics Inc.

Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.

About NRIM Northrim BanCorp Inc

Northrim BanCorp Inc is a bank holding company. The company operates in two segments: Community Banking and Home Mortgage Lending. It generates maximum revenue from the Community Banking segment. It offers to spend and save products such as checking, savings, money market accounts, debit cards, cashback rewards, and credit cards. It also includes loans and credit lines, mortgage loans, investment, and plan products.

Share on Social Networks: